Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse HAS1 ELISA Kit (AC3380)
Cat.#: ASET-1969
Specifications
Description Mouse HAS1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse HAS1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 1.53 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 30-480 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1732 Mouse Eph Receptor A2 ELISA Kit (AC3143) Quantitative inquiry ASET-1271 Human Nestin ELISA Kit (AC2682) Quantitative inquiry ASET-1145 Rat PMP22 ELISA Kit (AC2556) Quantitative inquiry ASET-1834 Mouse P2Y1 ELISA Kit (AC3245) Quantitative inquiry ASET-1542 Human SLUG ELISA Kit (AC2953) Quantitative inquiry ASET-1140 Human MT3 ELISA Kit (AC2551) Quantitative inquiry ASET-2448 Rat Galectin 3 ELISA Kit (AC3859) Quantitative inquiry ASET-1233 Human TAS2R38 ELISA Kit (AC2644) Quantitative inquiry ASET-2340 Mouse alpha MSH ELISA Kit (AC3751) Quantitative inquiry ASET-2296 Human ATG9A ELISA Kit (AC3707) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket